Sai Life Sciences is a company operating in the pharmaceutical industry.
Sai Life Sciences is a full-service CDMO driven by a vision to support the launch of 25 new medicines by 2025. It works with innovator pharma and biotech companies across USA, EU & Japan, accelerating the discovery, development and manufacture of complex small molecules. Over the past two decades, Sai Life Sciences has consistently delivered on a diverse set of NCE development programs for its customers with a track record of bringing value based on quality, pricing and responsiveness. Today, as one of India’s fastest growing CDMO companies, Sai Life Sciences works with the leading large pharma companies, as well as several small and mid-sized pharma & biotech companies. Sai Life Sciences is backed by committed long-term investors, TPG Capital and HBM Healthcare Investments.
Company type
Products and services
Biopharmaceuticals, Custom Manufacturing, Intermediates, Fine and Specialty Chemicals, Pharmaceutical Packaging, APIs (Active Pharmaceutical Ingredients), Contract Services – Analytical & Lab Services, Pharmaceutical Machinery & Technology
Markets
Oceania, North America (USA, Canada), Africa, Middle East Region (e.g. UAE), Central America (e.g. Mexico), East Asia (e.g. China, Japan, Korea), Europe – EU countries, Europe – non EU (e.g. UK, Russia, ex-CIS countries), South America (e.g. Brazil, Colombia), South Asia (e.g. India, Pakistan, Sri Lanka), South East Asia (e.g. Thailand, Philippines, Singapore)
Useful Links
Connect with Sai Life Sciences on LinkedIn
Address
Sai Life Sciences, Office No. L4-01 and 02, 4th Floor, SLN Terminus, SLN Terminus, Hyderabad, India, 500 032
